Accepted for Publication: June 6, 2022.
Published: July 25, 2022. doi:10.1001/jamanetworkopen.2022.23394
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Shulman R et al. JAMA Network Open.
Corresponding Author: Rayzel Shulman, MD, PhD, Division of Endocrinology, Hospital for Sick Children, 555 University Ave, Toronto, ON M5G 1X8, Canada (rayzel.shulman@sickkids.ca).
Author Contributions: Ms Diong and Dr Guttmann had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Shulman, Cohen, Stukel, Guttmann.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Shulman.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Stukel, Diong.
Obtained funding: Guttmann.
Supervision: Stukel, Guttmann.
Conflict of Interest Disclosures: Dr Shulman reported receiving personal fees from Dexcom outside the submitted work. Drs Shulman, Cohen, Stukel, and Guttmann reported receiving grants from the Canadian Institutes of Health Research during the conduct of the study and outside the submitted work. No other disclosures were reported.
Funding/Support: This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health. This study was also supported by grant VR4-172730 from the Canadian Institutes of Health Research (Dr Guttmann).
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario Ministry of Health is intended or should be inferred. Parts of this material are based on data and information compiled and provided by the Canadian Institute for Health Information (CIHI). However, the analyses, conclusions, opinions, and statements expressed herein are those of the authors, and not necessarily those of CIHI.
1.Barrett
CE , Koyama
AK , Alvarez
P ,
et al. Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years—United States, March 1, 2020-June 28, 2021.
MMWR Morb Mortal Wkly Rep. 2022;71(2):59-65. doi:
10.15585/mmwr.mm7102e2
PubMedGoogle ScholarCrossref 3.Kamrath
C , Rosenbauer
J , Eckert
AJ ,
et al. Incidence of type 1 diabetes in children and adolescents during the COVID-19 pandemic in Germany: results from the DPV Registry.
Diabetes Care. 2022;dc210969. doi:
10.2337/dc21-0969
PubMedGoogle ScholarCrossref